CARDIOMYOPATHY
Genotype-phenotype assessment in autosomal recessive arrhythmogenic right ventricular cardiomyopathy (Naxos disease) caused by a deletion in plakoglobin
Nikos Protonotarios, MD*,*  ,
Adalena Tsatsopoulou, MD*,
Aris Anastasakis, MD,
Elias Sevdalis, MD,
Godfrina McKoy, PhD ,
Kostas Stratos, MD,
Kostas Gatzoulis, MD,
Kostas Tentolouris, MD,
Chara Spiliopoulou, MD ,
Demos Panagiotakos, PhD,
William McKenna, MD, FRCP, FACC and
Paulos Toutouzas, MD, FACC
* Yannis Protonotarios Medical Center, Naxos, Greece
Department of Cardiology, University of Athens, Athens, Greece
Department of Cardiological Sciences, St. George’s Hospital Medical School, London, United Kingdom
Department of Forensic Medicine and Toxicology, University of Athens, Athens, Greece
Manuscript received February 28, 2001;
revised manuscript received June 11, 2001,
accepted July 11, 2001.
* Reprint requests and correspondence: Dr. Nikos I. Protonotarios, Yannis Protonotarios, Medical Centre of Naxos, Hora Naxos 84 300, Greece
adalena{at}otenet.gr
OBJECTIVES
The purpose of this study was to examine the genotype-phenotype relation with respect to penetrance, age and severity of expression, disease progression and prognosis in a recessively inherited arrhythmogenic right ventricular cardiomyopathy (ARVC).
BACKGROUND
Naxos disease is a recessively inherited ARVC caused by a mutation in the gene encoding plakoglobin (cell adhesion protein) in which the cardiac phenotype is associated with palmoplantar keratoderma and woolly hair.
METHODS
Twelve families with Naxos disease underwent cardiac and molecular genetic investigation. Serial cardiac assessment with annual resting 12-lead and 24-h ambulatory electrocardiogram (ECG) and two-dimensional echocardiography was performed during 1 to 16 years, median 7 ± 6 years in all 78 surviving members.
RESULTS
Twenty-eight surviving members were homozygous and 40 were heterozygous for the mutation. All adults who were homozygous (n = 26) fulfilled the diagnostic criteria for ARVC, the youngest by the age of 13 years. In eight who were heterozygous, minor ECG or echocardiographic abnormalities were observed. Of the 26 subjects who were affected homozygotes, 92% showed ECG abnormalities, 92% ventricular arrhythmias, 100% right ventricular structural alterations and 27% left ventricular involvement. During follow-up (10 ± 6 years), 16 (62%) developed structural progression, 12 (46%) arrhythmic events and 7 (27%) heart failure. The annual disease-related and sudden death mortality was 3% and 2.3%, respectively.
CONCLUSIONS
Autosomal recessive ARVC caused by a mutation in plakoglobin was 100% penetrant by adolescence. Affected subjects who were homozygous experienced progressive disease with adverse prognosis. A minority of subjects who were heterozygous showed minor ECG/echocardiographic changes, but clinically significant disease did not develop.
|
Abbreviations and Acronyms
| | ARVC | = arrhythmogenic right ventricular cardiomyopathy | | CI | = confidence interval | | ECG | = electrocardiogram | | LBBB | = left bundle branch block | | VT | = ventricular tachycardia |
|
This article has been cited by other articles:
|
|
|
|
 
Z. A. Bhuiyan, J. D.H. Jongbloed, J. van der Smagt, P. M. Lombardi, A. C.P. Wiesfeld, M. Nelen, M. Schouten, R. Jongbloed, M. G.P.J. Cox, M. van Wolferen, et al.
Desmoglein-2 and Desmocollin-2 Mutations in Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomypathy Patients: Results From a Multicenter Study
Circ Cardiovasc Genet,
October 1, 2009;
2(5):
418 - 427.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Dalal, H. Tandri, D. P. Judge, N. Amat, R. Macedo, R. Jain, C. Tichnell, A. Daly, C. James, S. D. Russell, et al.
Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study.
J. Am. Coll. Cardiol.,
April 14, 2009;
53(15):
1289 - 1299.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Dalal, R. Jain, H. Tandri, J. Dong, S. M. Eid, K. Prakasa, C. Tichnell, C. James, T. Abraham, S. D. Russell, et al.
Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
J. Am. Coll. Cardiol.,
July 31, 2007;
50(5):
432 - 440.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A A Tsatsopoulou, N I Protonotarios, and W J McKenna
Arrhythmogenic right ventricular dysplasia, a cell adhesion cardiomyopathy: insights into disease pathogenesis from preliminary genotype--phenotype assessment
Heart,
December 1, 2006;
92(12):
1720 - 1723.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Antoniades, A. Tsatsopoulou, A. Anastasakis, P. Syrris, A. Asimaki, D. Panagiotakos, C. Zambartas, C. Stefanadis, W. J. McKenna, and N. Protonotarios
Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis
Eur. Heart J.,
September 2, 2006;
27(18):
2208 - 2216.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Dalal, L. H. Molin, J. Piccini, C. Tichnell, C. James, C. Bomma, K. Prakasa, J. A. Towbin, F. I. Marcus, P. J. Spevak, et al.
Clinical Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated With Mutations in Plakophilin-2
Circulation,
April 4, 2006;
113(13):
1641 - 1649.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Bauce, C. Basso, A. Rampazzo, G. Beffagna, L. Daliento, G. Frigo, S. Malacrida, L. Settimo, G. Danieli, G. Thiene, et al.
Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations
Eur. Heart J.,
August 2, 2005;
26(16):
1666 - 1675.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. S. Grossmann, C. Grund, J. Huelsken, M. Behrend, B. Erdmann, W. W. Franke, and W. Birchmeier
Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation
J. Cell Biol.,
October 11, 2004;
167(1):
149 - 160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Zipes
The year in electrophysiology
J. Am. Coll. Cardiol.,
April 7, 2004;
43(7):
1306 - 1314.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Basso, T. Wichter, G. A Danieli, D. Corrado, E. Czarnowska, G. Fontaine, W. J McKenna, A. Nava, N. Protonotarios, L. Antoniades, et al.
Arrhythmogenic right ventricular cardiomyopathy: clinical registry and database, evaluation of therapies, pathology registry, DNA banking
Eur. Heart J.,
March 2, 2004;
25(6):
531 - 534.
[Full Text]
[PDF]
|
|
|
|
